Sylvie Beaudenon-Huibregtse

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Asuragen, Inc., Interpace Diagnostics Corporation. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sylvie Beaudenon-Huibregtse. Retrieved from https://idiyas.com/inventor/sylvie-beaudenon-huibregtse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4 (Patent Applications = 4)

% Patents Active = 50.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

Interpace Diagnostics Corporation

patents

Years Active: 2013-2021

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11118231 - miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms (2021-09-14),

2. 10150999 - miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms (2018-12-11),

3. 9080215 - MicroRNAs differentially expressed in cervical cancer and uses thereof (2015-07-14),

4. 8361714 - Micrornas differentially expressed in cervical cancer and uses thereof (2013-01-29),

Title: Sylvie Beaudenon-Huibregtse: Innovator in Thyroid Cancer Diagnostics

Introduction

Sylvie Beaudenon-Huibregtse is a prominent inventor based in Austin, TX (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of thyroid cancer. With a total of 4 patents, her work focuses on utilizing microRNAs (miRNAs) as biomarkers for distinguishing between benign and malignant thyroid neoplasms.

Latest Patents

One of her latest patents involves methods and compositions for identifying a miRNA profile for conditions such as thyroid nodules or thyroid cancer. This invention aims to enhance the diagnostic process for patients, allowing for more accurate identification of their conditions. The innovative approach she has developed is crucial for improving patient outcomes in thyroid-related health issues.

Career Highlights

Throughout her career, Sylvie has worked with notable companies, including Interpace Diagnostics Corporation and Asuragen, Inc. Her experience in these organizations has allowed her to apply her research and innovations in practical settings, contributing to advancements in medical diagnostics.

Collaborations

Sylvie has collaborated with esteemed colleagues such as Ashish Choudhary and Emmanuel Labourier. These partnerships have further enriched her research and development efforts in the field of thyroid cancer diagnostics.

Conclusion

Sylvie Beaudenon-Huibregtse's work exemplifies the impact of innovation in medical diagnostics, particularly in the realm of thyroid cancer. Her contributions through patents and collaborations continue to pave the way for advancements in patient care and diagnosis.

Profile summary based on public USPTO records.